Efficacy of lacosamide add-on therapy on Refractory Focal Epilepsies in children and adolescents: An open-label clinical trial
Objective: Epilepsy is a chronic neurological disorder that affects 0.5%–1% of children. 30%–40% of patients are resistant to current anti-epileptic drugs. Lacosamide (LCM) appeared to be effective, safe, and well tolerated in children and adolescents. This study was aimed to evaluate whether LCM co...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Wolters Kluwer Medknow Publications
2022-01-01
|
| Schriftenreihe: | Journal of Research in Pharmacy Practice |
| Schlagworte: | |
| Online-Zugang: | http://www.jrpp.net/article.asp?issn=2319-9644;year=2022;volume=11;issue=3;spage=109;epage=115;aulast=Mohammadi |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|